 An exploratory study will be conducted to identify micro environmental features in the tumor that are permissive of tumor immunity i.e: those associated with a response to anti-CTLA4 and to assess whether anti-CTLA4 causes peripheral mobilization of immunomodulatory inflammatory cells. 